14 September 2020>: Clinical Research
Do We Need to Distinguish Thrombolysis and Nonthrombolysis Patients When Applying Stroke-Associated Pneumonia Predicting Scores? An External Validation from a 2-Center Database
Jiao Jiao 123ABCDEF , Leiyu Geng 123BG , Zhijun Zhang 123ADF*DOI: 10.12659/MSM.924129
Med Sci Monit 2020; 26:e924129
Table 2 Diagnostic indexes in entire group and subgroups.
Cut-off | Entire group | |||||
---|---|---|---|---|---|---|
Sensitivity | Specificity | PPV | NPV | Youden Index | ||
PANTHERIS# | 5 | 0.78 | 0.84 | 0.68 | 0.90 | 0.62 |
PANTHERIS* | 1 | 0.85 | 0.52 | 0.36 | 0.92 | 0.37 |
AIS-APS# | 8 | 0.79 | 0.77 | 0.31 | 0.97 | 0.56 |
AIS-APS* | 11 | 0.61 | 0.84 | 0.55 | 0.87 | 0.45 |
A2DS2# | 4/5 | 0.91 | 0.57 | 0.14 | 0.99 | 0.48 |
A2DS2* | 1 | 0.51 | 0.80 | 0.90 | 0.30 | 0.31 |
ISAN# | - | – | – | – | – | – |
ISAN* | 8 | 0.63 | 0.80 | 0.51 | 0.87 | 0.43 |
PANTHERIS# | 5 | – | – | – | – | – |
PANTHERIS* | 1 | 0.83 | 0.66 | 0.27 | 0.96 | 0.49 |
AIS-APS# | 8 | – | – | – | – | – |
AIS-APS* | 11 | 0.94 | 0.52 | 0.23 | 0.98 | 0.46 |
A2DS2# | 4/5 | – | – | – | – | – |
A2DS2* | 1 | 0.67 | 0.80 | 0.33 | 0.94 | 0.47 |
ISAN# | - | – | – | – | – | – |
ISAN* | 8 | 0.83 | 0.58 | 0.23 | 0.96 | 0.41 |
PANTHERIS# | 5 | – | – | – | – | – |
PANTHERIS* | 1 | 0.43 | 0.82 | 0.57 | 0.72 | 0.25 |
AIS-APS# | 8 | – | – | – | – | – |
AIS-APS* | 11 | 0.65 | 0.87 | 0.73 | 0.82 | 0.52 |
A2DS2# | 4/5 | – | – | – | – | – |
A2DS2* | 1 | 0.67 | 0.75 | 0.60 | 0.81 | 0.42 |
ISAN# | – | – | – | – | – | – |
ISAN* | 8 | 0.67 | 0.73 | 0.58 | 0.80 | 0.40 |
# Derived from original cohort; * derived from our study. |